Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
| Website: | www.galmedpharma.com |
| Main Phone: | +972 36938448 |
| Address: | 16 Ze\'ev Tiomkin Street |
| City / Town: | Tel Aviv |
| Country: | ISR |
| Postal Code: | 6578317 |
| Exchange: | NSC |
| Employees: | 15 |
| NAICS: | Pharmaceutical P |
| Last Price 5.07 | Change $ 0.21 | Change % 4.32 | Tick N/A |
| Bid 3.15 | Bid Size 100.00 | Ask N/A | Ask Size 0.00 |
| Open 4.89 | High 5.08 | Low 4.89 | Prev Close 4.86 |
| Last Trade | Volume 2,899 | 52 Wk Hi 5.79 | 52 Wk Low 2.78 |
| Market Cap 61.7 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 12,168,912.00 | EPS (TTM) -1.39 | PE Ratio N/A | Exchange NCM |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 20 | 20 | 24 | 20 |
| Low Target Price Estimate | 6 | 6 | 6 | 6 |
| Mean Target Price Estimate | 13.4 | 13.4 | 18.2 | 13.4 |
| Standard Deviation | 6.11 | 6.11 | 7.09 | 6.11 |
| Date of Most Recent Estimate | 08/04/16 | 08/04/16 | 07/06/16 | 08/04/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 24 | 2016-08-03 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6 | 2016-08-01 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 7 | 2016-07-28 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 7 | 2016-06-30 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 5 | 2016-06-07 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 5 | 2016-06-01 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 82 | 2016-06-01 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 54 | 2016-06-01 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 3 | 2016-05-26 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 25 | 2016-05-16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
